Clinical Trial: A Qualitative Study of Information-Seeking and Decision-Making Regarding Gender-Affirming Hormone Therapy among Individuals with Gender Dysphoria or Gender Incongruence (Japan)

Tokyo, July 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061580) titled 'A Qualitative Study of Information-Seeking and Decision-Making Regarding Gender-Affirming Hormone Therapy among Individuals with Gender Dysphoria or Gender Incongruence' on July 15.

Study Type: Observational

Primary Sponsor: Institute - Department of Urology, Graduate school of Medicine, Nagoya University

Condition: Condition - Gender Incongruence Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to clarify how individuals with gender dysphoria or gender incongruence who have considered or experienced hormone therapy seek and refer to information about hormone therapy, and how they position healthcare professionals, family, friends, and online information in their decision-making regarding the initiation, continuation, discontinuation, and revision of treatment methods. The results will serve as foundational data for considering how to support individuals in safely and confidently accessing information and making decisions in consultation with healthcare professionals. Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Individuals who recognize themselves as having gender dysphoria, gender incongruence, or a related experience. Individuals who are considering, about to start, have started, are currently undergoing, have discontinued, or have previously undergone hormone therapy. Key exclusion criteria - Individuals who, according to the principal investigator or co-investigator, would experience significant psychological distress as a result of participating in the study. Individuals who are unable to participate in the study due to severe mental or physical symptoms. Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 05 Month 14 Day Anticipated trial start date - 2026 Year 07 Month 15 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070451

Disclaimer: Curated by HT Syndication.